A phase 3 trial of Abiraterone acetate, Bicalutamide, Degarelix, Docetaxel, Flutamide, Goserelin / leuprolide, Histrelin, Leuprolide, Nilutamide, Prednisone and Triptorelin in Prostate cancer, run by SWOG Cancer Research Network, now recruiting.
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer is a phase 3 interventional study registered as NCT03678025 by SWOG Cancer Research Network, with 1273 participants planned, started 2018-09-24 and due to reach its primary completion in 2028-04-01. Interventions recorded: Abiraterone, Bicalutamide, Degarelix, Docetaxel, Flutamide, Goserelin Acetate, Histrelin Acetate, Leuprolide Acetate, Nilutamide, Orchiectomy, Prednisone, Quality-of-Life Assessment, Radiation Therapy, Radical Prostatectomy, Triptorelin. Conditions recorded: Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma, Stage IV Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8, Stage IVB Prostate Cancer AJCC v8.
Linked to the drug Flutamide because the registry names it among its interventions and Prostate cancer among its conditions. Registry record only: no result has been read by an editor.
Shares Histrelin, Flutamide, Degarelix, Triptorelin and the tag pipeline.
Shares Nilutamide, Flutamide, Bicalutamide, Goserelin / leuprolide (ovarian function suppression) and the tag pipeline.
Shares Flutamide, Degarelix, Triptorelin, Bicalutamide and the tag pipeline.
Shares Nilutamide, Flutamide, Bicalutamide, Goserelin / leuprolide (ovarian function suppression) and the tag pipeline.
Shares Degarelix, Triptorelin, Bicalutamide, Leuprolide (leuprorelin) and GnRH agonists and the tag pipeline.
Shares Flutamide, Goserelin / leuprolide (ovarian function suppression), Leuprolide (leuprorelin) and GnRH agonists, Prostate cancer and the tag pipeline.
Shares Degarelix, Triptorelin, Goserelin / leuprolide (ovarian function suppression), Leuprolide (leuprorelin) and GnRH agonists and the tag pipeline.
Shares Degarelix, Bicalutamide, Goserelin / leuprolide (ovarian function suppression), Prostate cancer and the tag pipeline.